Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$0.75 - $1.1 $264,525 - $387,970
-352,700 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$0.52 - $0.92 $140,244 - $248,124
269,700 Added 324.94%
352,700 $273,000
Q4 2019

Jan 27, 2020

BUY
$0.63 - $2.27 $52,290 - $188,410
83,000 New
83,000 $188,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.